RE: Ex-div today13 Nov 2017 23:16
Hi Matt,
Had these on my watch list for a while and now may be a good entry price.
The fundamentals are to die for but just not too certain about outlook, will Troponin and VitD sustain growth?, the BOD are as ever conservative in their forecasts but they have �1m of revenue to make up 17/18 and seem to be relying on Troponin alone and intimate VitD will see modest / plateau sales..........so what will 17/18 revenue look like (million dollar question!)?, personally think it will be okay even if VitD only modest (say +10% to +15%) growth, there is China, and back in FY 15/16 they were predicting that Tropinin would have covered the lost revenue of �700k to �800k for 17/18 but this is now cited at �1m.....difficult to predict and value this one, but love the business model, barriers to entry, the BOD and the fundamentals, just don�t know if it�s now slightly over valued.
DD